24
Sep
Mumbai (Maharashtra) [India], September 23: HVAX Technologies Limited (NSE -HVAX), a turnkey pharmaceutical project integrator, has announced key business highlights that reinforce its strong growth trajectory. Order Book and Pipeline HVAX reported a consolidated order book of ₹312.58 Cr as of September 2025. In addition, the company is actively engaged in negotiations for projects worth ₹681.53 Cr. Strategic Growth Moves HVAX has aggressively begun penetrating the hospital industry and remains optimistic about achieving a breakthrough in the near future. The company has also started evaluating opportunities in the semiconductor and solar industries. The company aims to evaluate and acquire businesses by leveraging existing relationships with partners already serving…
